SYBX
Price
$1.48
Change
+$0.02 (+1.37%)
Updated
Aug 25, 04:54 PM (EDT)
Capitalization
17.08M
TECH
Price
$56.73
Change
-$0.36 (-0.63%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
8.95B
71 days until earnings call
Interact to see
Advertisement

SYBX vs TECH

Header iconSYBX vs TECH Comparison
Open Charts SYBX vs TECHBanner chart's image
Synlogic
Price$1.48
Change+$0.02 (+1.37%)
Volume$300
Capitalization17.08M
Bio-Techne
Price$56.73
Change-$0.36 (-0.63%)
Volume$66.66K
Capitalization8.95B
SYBX vs TECH Comparison Chart in %
Loading...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.86B. The market cap for tickers in the group ranges from 58 to 101.31B. VRTX holds the highest valuation in this group at 101.31B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 19%, and the average quarterly price growth was 29%. THAR experienced the highest price growth at 250%, while CLDI experienced the biggest fall at -67%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 15%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was 123%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 57
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -13 (-100 ... +100)

Market Cap

The average market capitalization across the group is 4.48B. The market cap for tickers in the group ranges from 17.08M to 8.95B. TECH holds the highest valuation in this group at 8.95B. The lowest valued company is SYBX at 17.08M.

High and low price notable news

The average weekly price growth across all stocks in the group was 3%. For the same group, the average monthly price growth was -3%, and the average quarterly price growth was -2%. TECH experienced the highest price growth at 7%, while SYBX experienced the biggest fall at -1%.

Volume

The average weekly volume growth across all stocks in the group was -10%. For the same stocks of the group, the average monthly volume growth was -45% and the average quarterly volume growth was 52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 17
Price Growth Rating: 53
SMR Rating: 87
Profit Risk Rating: 100
Seasonality Score: -62 (-100 ... +100)
VS
SYBX vs. TECH commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYBX is a Buy and TECH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (SYBX: $1.46 vs. TECH: $57.09)
Brand notoriety: SYBX and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYBX: 17% vs. TECH: 68%
Market capitalization -- SYBX: $17.08M vs. TECH: $8.95B
SYBX [@Biotechnology] is valued at $17.08M. TECH’s [@Biotechnology] market capitalization is $8.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TECH’s FA Score shows that 2 FA rating(s) are green whileSYBX’s FA Score has 1 green FA rating(s).

  • TECH’s FA Score: 2 green, 3 red.
  • SYBX’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than SYBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYBX’s TA Score shows that 5 TA indicator(s) are bullish while TECH’s TA Score has 6 bullish TA indicator(s).

  • SYBX’s TA Score: 5 bullish, 3 bearish.
  • TECH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both SYBX and TECH are a good buy in the short-term.

Price Growth

SYBX (@Biotechnology) experienced а -1.35% price change this week, while TECH (@Biotechnology) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($8.95B) has a higher market cap than SYBX($17.1M). TECH has higher P/E ratio than SYBX: TECH (124.11) vs SYBX (6.36). SYBX YTD gains are higher at: 4.286 vs. TECH (-20.398). TECH has higher annual earnings (EBITDA): 283M vs. SYBX (-11.07M). SYBX has less debt than TECH: SYBX (0) vs TECH (423M). TECH has higher revenues than SYBX: TECH (1.21B) vs SYBX (0).
SYBXTECHSYBX / TECH
Capitalization17.1M8.95B0%
EBITDA-11.07M283M-4%
Gain YTD4.286-20.398-21%
P/E Ratio6.36124.115%
Revenue01.21B-
Total Cash17MN/A-
Total Debt0423M-
FUNDAMENTALS RATINGS
TECH vs SYBX: Fundamental Ratings
TECH
SYBX
OUTLOOK RATING
1..100
6187
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8094
PRICE GROWTH RATING
1..100
5453
P/E GROWTH RATING
1..100
1124
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is significantly better than the same rating for SYBX (85). This means that TECH’s stock grew significantly faster than SYBX’s over the last 12 months.

TECH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SYBX (100). This means that TECH’s stock grew similarly to SYBX’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as SYBX (94). This means that TECH’s stock grew similarly to SYBX’s over the last 12 months.

SYBX's Price Growth Rating (53) in the Biotechnology industry is in the same range as TECH (54). This means that SYBX’s stock grew similarly to TECH’s over the last 12 months.

TECH's P/E Growth Rating (11) in the Biotechnology industry is in the same range as SYBX (24). This means that TECH’s stock grew similarly to SYBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SYBXTECH
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
70%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPTH4.030.24
+6.33%
LightPath Technologies
GIGM1.500.04
+2.74%
GigaMedia Limited
AKRO49.230.94
+1.95%
Akero Therapeutics
CAPL21.090.20
+0.96%
CrossAmerica Partners LP
ACGL93.41-0.13
-0.14%
Arch Capital Group Ltd

SYBX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with NEUP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
+4.29%
NEUP - SYBX
64%
Loosely correlated
+3.76%
BTAI - SYBX
37%
Loosely correlated
-4.78%
SBHMY - SYBX
34%
Loosely correlated
N/A
MDGL - SYBX
31%
Poorly correlated
+1.86%
MEIP - SYBX
29%
Poorly correlated
+7.58%
More

TECH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with AXON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
+5.72%
AXON - TECH
61%
Loosely correlated
+0.36%
SYRE - TECH
48%
Loosely correlated
+3.58%
ADPT - TECH
47%
Loosely correlated
+2.93%
MRNA - TECH
45%
Loosely correlated
+3.43%
CDXS - TECH
45%
Loosely correlated
+2.30%
More